These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Commentary: Limb-Based Patency for Chronic Limb-Threatening Ischemia Treatment: Do We Face a Threshold for Redefining Current Revascularization Practice? Alexandrescu VA; Houbiers A J Endovasc Ther; 2020 Aug; 27(4):595-598. PubMed ID: 32495681 [No Abstract] [Full Text] [Related]
11. Angiosome based time series analysis of deep tissue perfusion using diffuse speckle contrast analysis. Yeo CB; Lee KJ; Song C Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():4054-4057. PubMed ID: 29060787 [TBL] [Abstract][Full Text] [Related]
12. Commentary: Optimal Revascularization for Critical Limb Ischemia: One Approach Doesn't Always Fit All. Stegman BM; Shishehbor MH J Endovasc Ther; 2015 Aug; 22(4):482-4. PubMed ID: 26187972 [No Abstract] [Full Text] [Related]
14. One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia (Invited Commentary). Abularrage CJ Ann Vasc Surg; 2019 Nov; 61():33. PubMed ID: 31376539 [No Abstract] [Full Text] [Related]
15. A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. Alexandrescu V; Vincent G; Azdad K; Hubermont G; Ledent G; Ngongang C; Filimon AM J Endovasc Ther; 2011 Jun; 18(3):376-87. PubMed ID: 21679080 [TBL] [Abstract][Full Text] [Related]
16. Infrapopliteal arterial revascularization for limb-threatening ischemia in patients with chronic kidney disease. Ballotta E; Da Giau G; Piccoli A J Nephrol; 2007; 20(1):80-7. PubMed ID: 17347978 [TBL] [Abstract][Full Text] [Related]
17. Editor's Choice - A Prospective Study to Evaluate Complete Wound Healing and Limb Salvage Rates After Angiosome Targeted Infrapopliteal Balloon Angioplasty in Patients with Critical Limb Ischaemia. Elbadawy A; Ali H; Saleh M; Hasaballah A Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):392-397. PubMed ID: 29373203 [TBL] [Abstract][Full Text] [Related]